Moxifloxacin (Avalox®)

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

CompletedNCT01965431

Boehringer IngelheimHealthy

Start: 2013-10-31End: 2014-01-31Updated: 2016-04-14

Via Respimat® Inhaled BI 1744 CL Compared to Moxifloxacin and Placebo in Healthy Male and Female Volunteers

CompletedNCT02172144

Boehringer IngelheimHealthy

Start: 2007-06-30Updated: 2014-06-24